Black Diamond Therapeutics (BDTX) Earnings Date, Estimates & Call Transcripts $2.19 -0.03 (-1.35%) (As of 12/23/2024 05:26 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Black Diamond Therapeutics Latest Earnings SummaryActual EPS (Nov. 5) -$0.28 Beat By $0.09 Consensus EPS (Nov. 5) -$0.37 Black Diamond Therapeutics posted Q3 2024 earnings on November 5, 2024, reporting an EPS of -$0.28, which beat the consensus estimate of -$0.37 by $0.09. With a trailing EPS of -$1.33, Black Diamond Therapeutics' earnings are expected to grow next year, from ($1.30) to ($1.22) per share. Get Black Diamond Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Black Diamond Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBDTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BDTX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Black Diamond Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242-$0.44-$0.41-$0.43Q2 20242-$0.39-$0.35-$0.37Q3 20242-$0.40-$0.37-$0.39Q4 20242-$0.31-$0.29-$0.30FY 20248-$1.54-$1.42-$1.48Q1 20252-$0.31-$0.21-$0.26Q2 20252-$0.32-$0.22-$0.27Q3 20252-$0.32-$0.22-$0.27Q4 20252-$0.33-$0.18-$0.26FY 20258($1.28)($0.83)($1.06) Black Diamond Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/5/2024--$0.37-$0.28+$0.09-$0.28--8/6/2024Q2 2024-$0.39-$0.36+$0.03-$0.36--5/9/2024Q1 2024-$0.44-$0.35+$0.09-$0.35--3/12/2024Q4 2023-$0.47-$0.34+$0.13-$0.34--11/6/2023Q3 2023-$0.49-$0.45+$0.04-$0.45--8/11/2023Q2 2023-$0.54-$0.52+$0.02-$0.52-- Get the Latest News and Ratings for BDTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Black Diamond Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/9/2023Q1 2023-$0.61-$0.57+$0.04-$0.57--3/9/2023Q4 2022-$0.63-$0.59+$0.04-$0.59-- Black Diamond Therapeutics Earnings - Frequently Asked Questions When did Black Diamond Therapeutics announce their last quarterly earnings? Black Diamond Therapeutics (NASDAQ:BDTX) last announced its quarterly earning data on Tuesday, November 5, 2024. Learn more on BDTX's earnings history. Did Black Diamond Therapeutics beat their earnings estimates last quarter? In the previous quarter, Black Diamond Therapeutics (NASDAQ:BDTX) reported ($0.28) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.37) by $0.09. Learn more on analysts' earnings estimate vs. BDTX's actual earnings. How much profit does Black Diamond Therapeutics generate each year? Black Diamond Therapeutics (NASDAQ:BDTX) has a recorded net income of -$82.44 million. BDTX has generated -$1.33 earnings per share over the last four quarters. What is Black Diamond Therapeutics's EPS forecast for next year? Black Diamond Therapeutics's earnings are expected to grow from ($1.30) per share to ($1.22) per share in the next year. More Earnings Resources from MarketBeat Related Companies Cartesian Therapeutics Earnings Results MeiraGTx Earnings Results Zevra Therapeutics Earnings Results Esperion Therapeutics Earnings Results Arcturus Therapeutics Earnings Results Monte Rosa Therapeutics Earnings Results AnaptysBio Earnings Results Organogenesis Earnings Results SIGA Technologies Earnings Results KalVista Pharmaceuticals Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings Tiny Mineral, Massive Market Opportunity (Ad)Imagine a mineral so small it fits in the palm of your hand... yet its potential could transform the world's food supply. Right now, an under-the-radar company just debuted on the New York Stock Exchange with an IPO and it's currently priced under $15...Get the full name of this company by clicking here. This page (NASDAQ:BDTX) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersTiny Mineral, Massive Market OpportunityImagine a mineral so small it fits in the palm of your hand... yet its potential could transform the world's f...i2i Marketing Group, LLC | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored"This looks and feels like 2000," says investing legendOur senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says i...Stansberry Research | SponsoredA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading syst...Prosper Trading Academy | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Black Diamond Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Black Diamond Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
